Ashley C, Dunleavy A The renal drug handbook, 4th edn. London: Radcliffe Publishing; 2014
Barnes PJ, Drazen J, Rennard SI, Thomson NC Asthma and COPD: basic mechanisms and clinical management.London: Academic Press; 2009
Bearsley MB, Travis WD, Rubin E The respiratory system, 6th edn. In: Rubin R, Strayer DS (eds). Philadelphia (PA): Wolters Kluwer Health; 2012
Billington CK, Hall IP Real time analysis of 2-adrenoceptor-mediated signalling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.
Respir Res. 2011; 12:(1)
https://doi.org/10.1186/1465-9921-12-89
Boarder M, Newby D, Navti P Pharmacology for pharmacy and the health sciences: a patient-centred approach.Oxford: Oxford University Press; 2010
Boushey HA Drugs used in asthma, 12th edn. In: Katzung BG, Masters SB, Trevor AJ (eds). London: McGraw-Hill; 2012
British Lung Foundation. The battle for breath—the impact of lung disease in the UK. 2016.
https://tinyurl.com/yarq86a9 (accessed 24 June 2020)
Bush K -lactam antibiotics, 9th edn. In: Finch RG, Greenwood D, Whitley RJ, Norrby SR (eds). London: Elsevier; 2010
Crompton GK Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis Suppl. 1982; 119:101-104
De Alwis W, Weiner Y Emergency medicine MCQs.Sydney, Australia: Churchill Livingstone; 2012
Department of Health, Social Services and Public Safety. Service framework for respiratory health and wellbeing 2015-18. 2015.
https://tinyurl.com/y7qrd8a5 (accessed 24 June 2020)
Ebadi M Desk reference of clinical pharmacology, 2nd edn. London: CRC Press; 2008
Ehrhardt C, Kneuer C, Bies C, Lehr CM, Kim KJ, Bakowsky U Salbutamol is actively absorbed across human bronchial epithelial cell layers.
Pulm Pharmacol Ther. 2005; 18:(3)165-170
https://doi.org/10.1016/j.pupt.2004.11.007
Gardenhire DS Rau's respiratory care pharmacology, 9th edn. St. Louis (MO): Mosby/Elsevier; 2016
Geddes AM, Gould IM Ampicillin, amoxicillin and other ampicillin-like penicillin, 6th edn. In: Grayson ML, Crowe SM, McCarthy JS (eds.). London: CRC Press; 2010
Gladson B Pharmacology for rehabilitation professionals, 2nd edn. St. Louis (Mo): Elsevier; 2011
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2019.
https://tinyurl.com/y3blokvj (accessed 24 2020)
Goossens H, Ferech M, Vanderstichele R, Elseviers M Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.
Lancet. 2005; 365:(9459)579-587
https://doi.org/10.1016/S0140-6736(05)70799-6
Hinkle JL, Cheever KH Brunner and Suddarth's textbook of medical-surgical nursing, 13th edn. London: Lippincott Williams and Wilkins; 2014
Hodgson BB, Kizior RJ Saunders nursing drug handbook.St Louis (MO): Elsevier; 2014
Hurst JR, Perera WR, Wilkinson TMA, Donaldson GC, Wedzicha JA Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2006; 173:(1)71-78
https://doi.org/10.1164/rccm.200505-704OC
Jeske AH Mosby's dental drug reference, 11th edn. St. Louis (MO): Elsevier; 2014
Jones PW, Chen WH, Wilcox TK, Sethi S, Leidy NK Characterizing and quantifying the symptomatic features of COPD exacerbations.
Chest. 2011; 139:(6)1388-1394
https://doi.org/10.1378/chest.10-1240
Kaur SP, Rao R, Nanda S Amoxicillin: a broad spectrum antibiotic. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3:(3)30-37
Kee JL, Hayes ER, McCuiston LE Pharmacology: a patient-centred nursing process approach, 8th edn. St Louis (MO): Elsevier; 2015
Koch A, Pizzichini E, Hamilton A Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies.
Int J Chron Obstruct Pulmon Dis. 2014; 9:(1)697-714
https://doi.org/10.2147/COPD.S62502
Lilley LL, Rainforth Collins SR, Snyder JS Pharmacology and the nursing process, 8th edn. St Louis: Elsevier; 2017
Llor C, Moragas A, Hernández S, Bayona C, Miravitlles M Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2012; 186:(8)716-723
https://doi.org/10.1164/rccm.201206-0996OC
Lynes D Pathological processes aetiology and natural history. In: Lynes D (ed). Keswick: M&K Publishingl; 2007
MacNee W Pathology and pathogenesis. In: Currie GP (ed). Chichester: Wiley and Sons; 2011
Mahler DA, Kerwin E, Ayers T FLIGHT1 and FLIGHT2: efficacy and safety of QVA149 (indacaterol/glycopyrrolate) versus its monocomponents and placebo in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2015; 192:(9)1068-1079
https://doi.org/10.1164/rccm.201505-1048OC
Malhatra S, Shafique N Bronchodilators. In: Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R (eds). London: JP Medical Publishers; 2011
Masterton RG, Burley CJ Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Int J Antimicrob Agents. 2001; 18:(6)503-512
https://doi.org/10.1016/S0924-8579(01)00435-6
McFadden R Introducing pharmacology for nursing and healthcare, 2nd edn. London: Routledge; 2014
McIvor RA, Devlin HM, Kaplan A Optimizing the delivery of inhaled medication for respiratory patients: the role of valved holding chambers.
Can Respir J. 2018; 2018
https://doi.org/10.1155/2018/5076259
Miravitlles M, Kruesmann F, Haverstock D, Perroncel R, Choudhri SH, Arvis P Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
Eur Respir J. 2012; 39:(6)1354-1360
https://doi.org/10.1183/09031936.00042111
Nakpheng T, Songkarak S, Suwandecha T, Sritharadol R, Chunhachaichana C, Srichana T Evidences for salbutamol metabolism by respiratory and liver cell lines.
Drug Metab Pharmacokinet. 2017; 32:(2)127-134
https://doi.org/10.1016/j.dmpk.2016.11.006
National Institute for Clinical Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. 2019.
https://tinyurl.com/y3yftxc5 (accessed 25 June 2020)
Nau R, Sörgel F, Eiffert H Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.
Clin Microbiol Rev. 2010; 23:(4)858-883
https://doi.org/10.1128/CMR.00007-10
Newman SP, Pavia D, Garland N, Clarke SW Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl. 1982; 119:57-65
Porth CM Essentials of pathophysiology, 4th edn. Philadelphia (PA): Wolters Kluwer Health; 2015
Sanchis J, Gich I, Pedersen S Aerosol drug management improvement team. Systematic review of errors in inhaler use: has patient technique improved over time?.
Chest. 2016; 150:(2)394-406
https://doi.org/10.1016/j.chest.2016.03.041
Shapiro SD, Reilly JJ, Rennard SI Chronic bronchitis and emphysema, 5th edn. In: Mason JR, Broaddus VC, Martin TR (eds). Philadelphia (PA): Elsevier Saunders; 2010
Skidmore-Roth L Mosby's drug guide for nursing students, 11th edn. St Louis (MO): Elsevier; 2015
Vallerand AH, Sanoski CA, Deglin JH Davis's drug guide for nurses, 14th edn. Philadelphia (PA): FA Davis Company; 2015
van Geffen WH, Douma WR, Slebos DJ, Kerstjens HAM Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.
Cochrane Database Syst Rev. 2016; 29:(8)
https://doi.org/10.1002/14651858.CD011826.pub2
Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2012; 12
https://doi.org/10.1002/14651858.CD010257
Waller DG, Sampson AP, Renwick AG, Hillier K Medical pharmacology and therapeutics, 4th edn. London: Elsevier; 2014
Wedzicha JA, Decramer M, Ficker JH Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study.
Lancet Respir Med. 2013; 1:(3)199-209
https://doi.org/10.1016/S2213-2600(13)70052-3
West JB Pulmonary pathophysiology: the essentials, 9th edn. Philadelphia (PA): Wolters Kluwer Health; 2012
Wilkinson TMA, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of chronic obstructive pulmonary disease.
Chest. 2006; 129:(2)317-324
https://doi.org/10.1378/chest.129.2.317
Woo TM Drugs affecting the respiratory system, 4th edn. In: Woo TM, Robinson MV (eds). Philadelphia (PA): FA Davis Company; 2016
Yagiela JA, Dowd FJ, Johnson B, Mariotti A, Neidle EA Pharmacology and therapeutics for dentistry, 6th edn. St Louis (MO): Elsevier; 2011